{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:05:20Z","timestamp":1767143120383,"version":"build-2238731810"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s12253-019-00751-9","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T19:03:31Z","timestamp":1568228611000},"page":"1651-1656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Monoclonal Caveolin 1 Expression in the Differential Diagnosis of Malignant Pleural Mesothelioma and Pulmonary Adenocarcinoma: Is it Useful?"],"prefix":"10.1007","volume":"26","author":[{"given":"Zehra","family":"Bozdag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ediz","family":"Tutar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer Faruk","family":"Dizibuyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Bakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"751_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1183\/16000617.0063-2016","volume":"25","author":"AC Bibby","year":"2016","unstructured":"Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG et al (2016) Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev 25:472\u2013486","journal-title":"Eur Respir Rev"},{"issue":"17\u201318","key":"751_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00508-016-1080-z","volume":"128","author":"C Christian Geltner","year":"2016","unstructured":"Christian Geltner C, Errhalt P, Baumgartner B, Ambrosch G, Machan B (2016) Eckmayr J,; Austrian mesothelioma interest group (AMIG). Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : consensus of the Austrian Mesothelioma Interest Group (AMIG). Wien Klin Wochenschr 128(17\u201318):611\u2013617","journal-title":"Wien Klin Wochenschr"},{"key":"751_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","volume":"88","author":"P Beckett","year":"2015","unstructured":"Beckett P, Edwards J, Fennell D, Hubbard R, Woolhouse I, Peake MD (2015) Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer 88:344\u2013348","journal-title":"Lung Cancer"},{"key":"751_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5858\/arpa.2010-0604-RA","volume":"136","author":"PG Betta","year":"2012","unstructured":"Betta PG, Magnani C, Bensi T, Trincheri NF, Orecchia S (2012) Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma. Arch Pathol Lab Med 136:253\u2013261","journal-title":"Arch Pathol Lab Med"},{"key":"751_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.chest.2016.12.004","volume":"152","author":"J Creaney","year":"2017","unstructured":"Creaney J, Robinson BWS, Geltner C, Errhalt P, Baumgartner B, Ambrosch G, Austrian Mesothelioma Interest Group (AMIG) (2017) Malignant Mesothelioma. biomarkers: from discovery to use in clinical practice for diagnosis, monitoring, screening, and treatment. Chest 152:143\u2013149","journal-title":"Chest"},{"key":"751_CR6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/dc.21489","volume":"39","author":"XY Su","year":"2011","unstructured":"Su XY, Li GD, Liu WP, Xie B, Jiang YH (2011) Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn Cytopathol 39:900\u2013908","journal-title":"Diagn Cytopathol"},{"key":"751_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ajpath.2010.12.014","volume":"178","author":"F Gueugnon","year":"2011","unstructured":"Gueugnon F, Leclercq S, Blanquart C, Sagan C, Cellerin L, Padieu M, Perigaud C, Scherpereel A, Gregoire M (2011) Identification of novel markers for the diagnosis of malignant pleural mesothelioma. Am J Pathol 178:1033\u20131042","journal-title":"Am J Pathol"},{"key":"751_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","volume":"140","author":"A Churg","year":"2016","unstructured":"Churg A, Sheffield BS, Galateau-Salle F (2016) New markers for separating benign from malignant Mesothelial proliferations are we there yet? Arch Pathol Lab Med 140:318\u2013321","journal-title":"Arch Pathol Lab Med"},{"key":"751_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2147\/OTT.S123912","volume":"10","author":"P Fu","year":"2017","unstructured":"Fu P, Chen F, Pan Q, Zhao X, Zhao C, Cho WC et al (2017) The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma. Onco Targets Ther 10:819\u2013835","journal-title":"Onco Targets Ther"},{"key":"751_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2559.2009.03322.x","volume":"55","author":"VJ Amatya","year":"2009","unstructured":"Amatya VJ, Takeshima Y, Kohno H, Kushitani K, Yamada T, Morimoto C, Inai K (2009) Caveolin- 1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma. Histopathology 55:10\u201319","journal-title":"Histopathology"},{"key":"751_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000339259","volume":"83","author":"P Astoul","year":"2012","unstructured":"Astoul P, Roca E, GalateauSall\u00e9 F, Scherpereel A (2012) Malignant pleural mesothelioma: from the bench to the bedside. Respiration 83:481\u2013493","journal-title":"Respiration"},{"key":"751_CR12","unstructured":"Husain AN, Colby T, Ordonez NG et al (2012) Guidelines for pathologic diagnosis of malignant mesothelioma. Arch Pathol Lab Med 137"},{"key":"751_CR13","first-page":"817","volume":"53","author":"M Dinu","year":"2012","unstructured":"Dinu M, Ciurea RN, Stefan M, Georgescu AC (2012) The role of immunohistochemistry in the diagnosis of neoplastic pleural effusions. Rom J Morphol Embryol 53:817\u2013820","journal-title":"Rom J Morphol Embryol"},{"key":"751_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ctrv.2015.05.001","volume":"41","author":"V Panou","year":"2015","unstructured":"Panou V, Vyberg M, Weinreich UM, Meristoudis C, Falkmer UG, R\u00f8e OD (2015) The established and future biomarkers of malignant pleural mesothelioma. Cancer Treat Rev 41:486\u2013495","journal-title":"Cancer Treat Rev"},{"key":"751_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.12659\/AJCR.895661","volume":"17","author":"G Richter","year":"2016","unstructured":"Richter G, Heidersdorf H, Hirschfeld D, Krebbel F (2016 Mar 4) Positive TTF-1 expression in malignant mesothelioma: a case report. Am J Case Rep 17:133\u2013136","journal-title":"Am J Case Rep"},{"issue":"4","key":"751_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.anndiagpath.2015.03.007","volume":"19","author":"S Chaouche-Mazouni","year":"2015","unstructured":"Chaouche-Mazouni S, Scherpereel A, Zaamoum R, Mihalache A, Amir ZC, Leba\u00efli N, Delaire B, Gosset P (2015) Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma. Ann Diagn Pathol 19(4):193\u2013197","journal-title":"Ann Diagn Pathol"},{"key":"751_CR17","doi-asserted-by":"publisher","first-page":"59314","DOI":"10.18632\/oncotarget.10653","volume":"7","author":"M Carbone","year":"2016","unstructured":"Carbone M, Shimizu D, Napolitano A, Tanji M, Pass HI, Yang H, Pastorino S (2016) Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma. Oncotarget 7:59314\u201359321","journal-title":"Oncotarget"},{"key":"751_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12253-016-0135-9","volume":"23","author":"N Sahin","year":"2017","unstructured":"Sahin N, Akatli AN, Celik MR, Ulutas H, Samdanci ET, Colak C (2017) The role of CD90 in the differential diagnosis of pleural malignant mesothelioma, pulmonary carcinoma and comparison with Calret\u0131n\u0131n. Pathol Oncol Res 23:487\u2013491","journal-title":"Pathol Oncol Res"},{"key":"751_CR19","first-page":"94","volume":"29","author":"\u00d6 \u00dc\u00e7er","year":"2013","unstructured":"\u00dc\u00e7er \u00d6, Da\u011fli AF, Kili\u00e7arslan A, Arta\u015f G (2013) Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma. Turk Patoloji Derg 29:94\u2013100","journal-title":"Turk Patoloji Derg"},{"key":"751_CR20","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/modpathol.2016.181","volume":"30","author":"VJ Amatya","year":"2017","unstructured":"Amatya VJ, Kushitani K, Mawas AS, Miyata Y, Okada M, Kishimoto T et al (2017) MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Mod Pathol 30:672\u2013681","journal-title":"Mod Pathol"},{"key":"751_CR21","doi-asserted-by":"publisher","first-page":"84851","DOI":"10.18632\/oncotarget.12707","volume":"7","author":"R Ren","year":"2016","unstructured":"Ren R, Yin P, Zhang Y, Zhou J, Zhou Y, Xu R et al (2016) Diagnostic value of fibulin-3 for malignant pleural mesothelioma: a systematic review and meta-analysis. Oncotarget 7:84851\u201384859","journal-title":"Oncotarget"},{"key":"751_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1245\/s10434-013-3225-x","volume":"21","author":"Y Jia","year":"2014","unstructured":"Jia Y, Wang N, Wang J et al (2014) Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Ann Surg Oncol 21:329\u2013336","journal-title":"Ann Surg Oncol"},{"key":"751_CR23","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3892\/or.2011.1605","volume":"27","author":"P Zhan","year":"2012","unstructured":"Zhan P, Shen XK, Qian Q et al (2012) Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas. Oncol Rep 27:1072\u20131078","journal-title":"Oncol Rep"},{"key":"751_CR24","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.breast.2013.03.005","volume":"22","author":"X Ma","year":"2013","unstructured":"Ma X, Liu L, Nie W, Li Y, Zhang B, Zhang J, Zhou R (2013) Prognostic role of caveolin in breast cancer: a meta-analysis. Breast 22:462\u2013469","journal-title":"Breast"},{"key":"751_CR25","first-page":"977","volume":"29","author":"Y Tang","year":"2012","unstructured":"Tang Y, Zeng X, He F, Liao Y, Qian N, Toi M (2012) Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer. MedOncol 29:977\u2013984","journal-title":"MedOncol"},{"key":"751_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000341685","volume":"80","author":"KH Nam","year":"2013","unstructured":"Nam KH, Lee BL, Park JH, Kim J, Han N, Lee HE, Kim MA, Lee HS, Kim WH (2013) Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer. Pathobiology 80:87\u201394","journal-title":"Pathobiology"},{"key":"751_CR27","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/sj.bjc.6600619","volume":"87","author":"M Suzuoki","year":"2002","unstructured":"Suzuoki M, Miyamoto M, Kato K, Hiraoka K, Oshikiri T, Nakakubo Y, Fukunaga A, Shichinohe T, Shinohara T, Itoh T, Kondo S, Katoh H (2002) Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer 87:1140\u20131144","journal-title":"Br J Cancer"},{"key":"751_CR28","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3748\/wjg.v21.i4.1140","volume":"21","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Han FH, Yang SB, Hua LX, Wu JH, Zhan WH (2015) Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival. World J Gastroenterol 21:1140\u20131147","journal-title":"World J Gastroenterol"},{"key":"751_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1464-410X.2004.04604.x","volume":"93","author":"HJ Joo","year":"2004","unstructured":"Joo HJ, Oh DK, Kim YS, Lee KB, Kim SJ (2004) Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int 93:291\u2013296","journal-title":"BJU Int"},{"key":"751_CR30","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/pros.20557","volume":"67","author":"JA Karam","year":"2007","unstructured":"Karam JA, Lotan Y, Roehrborn CG, Ashfaq R, KarakiewiczPI SSF (2007) Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. Prostate 67:614\u2013622","journal-title":"Prostate"},{"key":"751_CR31","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1369\/jhc.4A6334.2004","volume":"52","author":"CJ von Ruhland","year":"2004","unstructured":"von Ruhland CJ, Campbell L, Gumbleton M, Jasani B, Newman GR (2004) Immunolocalization of caveolin-1 in rat and human mesothelium. J Histochem Cytochem 52:1415\u20131425","journal-title":"J Histochem Cytochem"},{"key":"751_CR32","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.pathol.2016.08.003","volume":"48","author":"B Thapa","year":"2016","unstructured":"Thapa B, Walkiewicz M, Murone C, Asadi K, Deb S, Barnett S, Knight S, Mitchell P, Liew D, Watkins DN, John T (2016) Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma. Pathology 48:660\u2013665","journal-title":"Pathology"},{"key":"751_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1309\/AJCP0F6WYBXGVDHX","volume":"141","author":"L Righi","year":"2014","unstructured":"Righi L, Cavallo MC, Gatti G, Monica V, Rapa I, Busso S et al (2014) Tumor\/stromal caveolin-1 expression patterns in pleural mesothelioma define a subgroup of the epithelial histotype with poorer prognosis. Am J Clin Pathol 141:816\u2013827","journal-title":"Am J Clin Pathol"},{"key":"751_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1365-2559.2003.01686.x","volume":"43","author":"RL Attanoos","year":"2003","unstructured":"Attanoos RL, Griffin A, Gibbs AR (2003) The use of immunohistochemistry distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology 43:231\u2013238","journal-title":"Histopathology"}],"updated-by":[{"DOI":"10.1007\/s12253-020-00793-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000}}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-019-00751-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T12:33:07Z","timestamp":1599741187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-019-00751-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1007\/s12253-019-00751-9","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"assertion":[{"value":"21 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article unfortunately contained an error in Fig. 1. Cav-1 expression in MPM and PA cases failed to show the histopathological details in Fig. 1 due to technical problem. The figure with the proper sharpness and clarity is shown in the next page.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}